Nafamostat mesylate, a synthetic serine protease inhibitor, it is a short-acting anticoagulant, and is also used for the treatment of pancreatitis and, It has been used in trials studying the prevention of Liver Transplantation and Postreperfusion Syndrome. Reference standards of Nafamostat Mesylate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Nafamostat Mesylate
Catalogue No.:PA 14 1310000
CAS :
Molecular Formula : C21H25N5O8S2
Molecular Weight : 539.58
6-Carbamimidoylnaphthalen-2-yl 4-(3-((4-(carbamoyloxy)phenyl)(imino)methyl)guanidino)benzoate
Catalogue No.:PA 14 1311000
Molecular Formula : C27H23N7O4
Molecular Weight : 509.53
6-Carbamimidoylnaphthalen-2-yl 4-(3-(4-guanidinobenzoyl)guanidino)benzoate
Catalogue No.:PA 14 1311001
Molecular Formula : C27H24N8O3
Molecular Weight : 508.54
4-(N'-(4-Guanidinobenzoyl)formohydrazonamido)benzoic Acid
Catalogue No.:PA 14 1311002
Molecular Formula : C16H16N6O3
Molecular Weight : 340.34
4-Guanidino-N-((6-hydroxynaphthalen-2-yl)(imino)methyl)benzamide
Catalogue No.:PA 14 1311003
Molecular Formula : C19H17N5O2
Molecular Weight : 347.38
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
